Surface plasmon resonance based on nanostructures has been a powerful analytical tool in rapid detection and analysis of biomolecules. However, the fabrication of nanostructure sensors, such as electron beam lithography and focused ion beam milling, has inherent defects as manufacturing cost, complex process flow, and small fabrication area. In this paper, using the transfer nanoprinting approach based on an ultrathin anodic aluminum oxide membrane, a centimeter-scale ordered periodic Ag-ZnS bilayer nanodisk on Au film with a low cost and simple process is fabricated. A surface plasmon polariton Bloch mode from nanodisk arrays is experimentally demonstrated at normal incident of light. The plasmonic platform exhibits an ideal refractive index bulk sensitivity of up to 438 nm/RIU. Furthermore, by using a polyelectrolyte bilayer with well-defined thickness, the surface sensitivity of the biosensing platform is also investigated. The large-scale plasmonic bilayer nanoparticle biosensing platform has broad application prospects in development of low-cost and high-performance biosensing chips.

Download full-text PDF

Source
http://dx.doi.org/10.1364/AO.499639DOI Listing

Publication Analysis

Top Keywords

biosensing platform
12
large-scale plasmonic
8
transfer nanoprinting
8
surface plasmon
8
plasmonic nanodisk
4
nanodisk array
4
biosensing
4
array biosensing
4
platform
4
platform fabricated
4

Similar Publications

Development of a multiplexed and sensitive biosensing platform is a priority for public health security. We report a micropore resistance counting platform based on polystyrene microsphere size-based encoding and Argonaute (CbAgo) decoding for multiplexed and ultrasensitive detection. Initially, we constructed a target DNA-modified polystyrene microsphere coding system based on micropore resistance counting.

View Article and Find Full Text PDF

Typical biosensing platforms are based on the "lock-and-key" approach, providing high specificity and sensitivity for environmental and food safety monitoring. However, they are limited in their ability to detect multiple analytes simultaneously. With the use of pattern identification methods, biosensor arrays can detect faint fluctuations caused by multiple analytes with similar properties in complex systems.

View Article and Find Full Text PDF

Although various sensors specifically developed for target analytes are available, affordable biosensing solutions with broad applicability are limited. In this study, a cost-effective biosensor for detecting human epidermal growth factor receptor 2 (HER2) was developed using custom-made gold leaf electrodes (GLEs). A novel strategy for antibody immobilization on a gold surface, for the first time mediated by protein L and HER2-specific antibody trastuzumab, was examined using commercial screen-printed gold electrodes and GLEs.

View Article and Find Full Text PDF

Leveraging Synthetic Antibody-DNA Conjugates to Expand the CRISPR-Cas12a Biosensing Toolbox.

ACS Synth Biol

January 2025

Department of Chemical Science and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy.

We report here the use of antibody-DNA conjugates (Ab-DNA) to activate the collateral cleavage activity of the CRISPR-Cas12a enzyme. Our findings demonstrate that Ab-DNA conjugates effectively trigger the collateral cleavage activity of CRISPR-Cas12a, enabling the transduction of antibody-mediated recognition events into fluorescence outputs. We developed two different immunoassays using an Ab-DNA as activator of Cas12a: the CRISPR-based immunosensing assay (CIA) for detecting SARS-CoV-2 spike S protein, which shows superior sensitivity compared with the traditional enzyme-linked immunosorbent assay (ELISA), and the CRISPR-based immunomagnetic assay (CIMA).

View Article and Find Full Text PDF

Biosensing for rapid detection of MDR, XDR and PDR bacteria.

Clin Chim Acta

December 2024

Infectious Disease, School of Aerospace and Subaquatic Medicine, Infectious Diseases & Tropical Medicine Research Center, Iran. Electronic address:

The emergence of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) bacteria poses a significant threat to global public health, complicating the management of infectious diseases and increasing morbidity and mortality rates. Rapid and sensitive detection of these resistant pathogens is crucial for effective treatment and infection control. This manuscript provides a comprehensive overview of various biosensor technologies developed for the rapid identification and quantification of MDR and XDR bacteria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!